セラス・ライフ・サイエンシズ・グループの掲示板の投稿コメント詳細

Patients who remain in remission after 52 weeks will receive treatment every 2 months (Q2M) in the second year of treatment. Patients who remain in remission after 2 years will be treated every 3 months (Q3M) until disease relapse.